🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
This trial is the cohort C part of a multicenter, open label Phase Ib/II cl...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2025-04-11
Trial ID
NCT06821503
This phase I/II trial tests the side effects and best dose of abemaciclib w...
Status
Recruiting
Location
UT MD Anderson Cancer Center
Start Date
2026-03-18
Trial ID
NCT06498648
Treatments Being Tested
This is a Phase Ib/II platform clinical study to evaluate the initial effic...
Status
Not Yet Recruiting
Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Start Date
2024-04-30
Trial ID
NCT06370754
This is a multicenter, randomized, controlled, open-label Phase III clinica...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2025-01-06
Trial ID
NCT06792253
Test the safety, immune response and efficacy of GVAX pancreas vaccine (wit...
Status
Completed
Location
Scottsdale Healthcare Research Institute
Start Date
2014-02-05
Trial ID
NCT02004262
Treatments Being Tested
The study is a phase II clinical trial of single arm. The purpose is to eva...
Status
Unknown
Location
Jiangmen central hospital
Start Date
2019-07-13
Trial ID
NCT03982680
Treatments Being Tested
This phase II trial is studying how well giving gemcitabine, paclitaxel, an...
Status
Completed
Location
Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield
Start Date
2007-04
Trial ID
NCT00478361
Treatments Being Tested
This research study will investigate the safety and effectiveness of two di...
Status
Completed
Location
University of Southern Alabama Mitchell Cancer Institute
Start Date
2008-10
Trial ID
NCT00771810
This study is a randomized controlled, open-label, multicenter phase III cl...
Status
Recruiting
Location
Erwei Song
Start Date
2023-12-01
Trial ID
NCT06079983